Fulminant type 1 diabetes mellitus induced by pembrolizumab in a patient with urothelial carcinoma: A case report

A case of fulminant type 1 diabetes mellitus secondary to administration of pembrolizumab in a patient with urothelial carcinoma is presented. Eight days after the third infusion of pembrolizumab, the patient presented with complaints of malaise and anorexia. The patient's laboratory data showe...

Descripción completa

Detalles Bibliográficos
Autores principales: Tohi, Yoichiro, Fujimoto, Kanta, Suzuki, Ryosuke, Suzuki, Issei, Kubota, Masashi, Kawakita, Mutsushi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Trauma and Reconstruction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6562295/
https://www.ncbi.nlm.nih.gov/pubmed/31211060
http://dx.doi.org/10.1016/j.eucr.2019.100849

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6562295/
https://www.ncbi.nlm.nih.gov/pubmed/31211060
http://dx.doi.org/10.1016/j.eucr.2019.100849

Ejemplares similares